The global market for Molecular Diagnostics Systems was valued at US$ 11900 million in the year 2024 and is projected to reach a revised size of US$ 16120 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Molecular Diagnostics Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Systems.

The Molecular Diagnostics Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnostics Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnostics Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Molecular Diagnostics Systems Market Report

Report Metric	Details
Report Name	Molecular Diagnostics Systems Market
Accounted market size in year	US$ 11900 million
Forecasted market size in 2031	US$ 16120 million
CAGR	4.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	PCR Hybridization DNA Sequencing
Segment by Application	Hospitals Laboratories
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation), Biomérieux Sa, Cepheid Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostics Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostics Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Molecular Diagnostics Systems Market growing?

Ans: The Molecular Diagnostics Systems Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Molecular Diagnostics Systems Market size in 2031?

Ans: The Molecular Diagnostics Systems Market size in 2031 will be US$ 16120 million.

Who are the main players in the Molecular Diagnostics Systems Market report?

Ans: The main players in the Molecular Diagnostics Systems Market are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation), Biomérieux Sa, Cepheid Inc

What are the Application segmentation covered in the Molecular Diagnostics Systems Market report?

Ans: The Applications covered in the Molecular Diagnostics Systems Market report are Hospitals, Laboratories

What are the Type segmentation covered in the Molecular Diagnostics Systems Market report?

Ans: The Types covered in the Molecular Diagnostics Systems Market report are PCR, Hybridization, DNA Sequencing

1 Molecular Diagnostics Systems Market Overview

1.1 Product Definition

1.2 Molecular Diagnostics Systems by Type

1.2.1 Global Molecular Diagnostics Systems Market Value Comparison by Type (2024 VS 2031)

1.2.2 PCR

1.2.3 Hybridization

1.2.4 DNA Sequencing

1.3 Molecular Diagnostics Systems by Application

1.3.1 Global Molecular Diagnostics Systems Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Laboratories

1.4 Global Molecular Diagnostics Systems Market Size Estimates and Forecasts

1.4.1 Global Molecular Diagnostics Systems Revenue 2020-2031

1.4.2 Global Molecular Diagnostics Systems Sales 2020-2031

1.4.3 Global Molecular Diagnostics Systems Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Molecular Diagnostics Systems Market Competition by Manufacturers

2.1 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2020-2025)

2.2 Global Molecular Diagnostics Systems Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Molecular Diagnostics Systems Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Molecular Diagnostics Systems, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Molecular Diagnostics Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Molecular Diagnostics Systems, Product Type & Application

2.7 Global Key Manufacturers of Molecular Diagnostics Systems, Date of Enter into This Industry

2.8 Global Molecular Diagnostics Systems Market Competitive Situation and Trends

2.8.1 Global Molecular Diagnostics Systems Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Molecular Diagnostics Systems Players Market Share by Revenue

2.8.3 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Molecular Diagnostics Systems Market Scenario by Region

3.1 Global Molecular Diagnostics Systems Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Molecular Diagnostics Systems Sales by Region: 2020-2031

3.2.1 Global Molecular Diagnostics Systems Sales by Region: 2020-2025

3.2.2 Global Molecular Diagnostics Systems Sales by Region: 2026-2031

3.3 Global Molecular Diagnostics Systems Revenue by Region: 2020-2031

3.3.1 Global Molecular Diagnostics Systems Revenue by Region: 2020-2025

3.3.2 Global Molecular Diagnostics Systems Revenue by Region: 2026-2031

3.4 North America Molecular Diagnostics Systems Market Facts & Figures by Country

3.4.1 North America Molecular Diagnostics Systems Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Molecular Diagnostics Systems Sales by Country (2020-2031)

3.4.3 North America Molecular Diagnostics Systems Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Molecular Diagnostics Systems Market Facts & Figures by Country

3.5.1 Europe Molecular Diagnostics Systems Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Molecular Diagnostics Systems Sales by Country (2020-2031)

3.5.3 Europe Molecular Diagnostics Systems Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Molecular Diagnostics Systems Market Facts & Figures by Region

3.6.1 Asia Pacific Molecular Diagnostics Systems Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Molecular Diagnostics Systems Sales by Region (2020-2031)

3.6.3 Asia Pacific Molecular Diagnostics Systems Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Molecular Diagnostics Systems Market Facts & Figures by Country

3.7.1 Latin America Molecular Diagnostics Systems Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Molecular Diagnostics Systems Sales by Country (2020-2031)

3.7.3 Latin America Molecular Diagnostics Systems Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Molecular Diagnostics Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Molecular Diagnostics Systems Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Molecular Diagnostics Systems Sales by Country (2020-2031)

3.8.3 Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Molecular Diagnostics Systems Sales by Type (2020-2031)

4.1.1 Global Molecular Diagnostics Systems Sales by Type (2020-2025)

4.1.2 Global Molecular Diagnostics Systems Sales by Type (2026-2031)

4.1.3 Global Molecular Diagnostics Systems Sales Market Share by Type (2020-2031)

4.2 Global Molecular Diagnostics Systems Revenue by Type (2020-2031)

4.2.1 Global Molecular Diagnostics Systems Revenue by Type (2020-2025)

4.2.2 Global Molecular Diagnostics Systems Revenue by Type (2026-2031)

4.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Type (2020-2031)

4.3 Global Molecular Diagnostics Systems Price by Type (2020-2031)

5 Segment by Application

5.1 Global Molecular Diagnostics Systems Sales by Application (2020-2031)

5.1.1 Global Molecular Diagnostics Systems Sales by Application (2020-2025)

5.1.2 Global Molecular Diagnostics Systems Sales by Application (2026-2031)

5.1.3 Global Molecular Diagnostics Systems Sales Market Share by Application (2020-2031)

5.2 Global Molecular Diagnostics Systems Revenue by Application (2020-2031)

5.2.1 Global Molecular Diagnostics Systems Revenue by Application (2020-2025)

5.2.2 Global Molecular Diagnostics Systems Revenue by Application (2026-2031)

5.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Application (2020-2031)

5.3 Global Molecular Diagnostics Systems Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Laboratories Molecular Diagnostics Systems Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Qiagen N.V.

6.2.1 Qiagen N.V. Company Information

6.2.2 Qiagen N.V. Description and Business Overview

6.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Qiagen N.V. Molecular Diagnostics Systems Product Portfolio

6.2.5 Qiagen N.V. Recent Developments/Updates

6.3 Roche Diagnostics

6.3.1 Roche Diagnostics Company Information

6.3.2 Roche Diagnostics Description and Business Overview

6.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Roche Diagnostics Molecular Diagnostics Systems Product Portfolio

6.3.5 Roche Diagnostics Recent Developments/Updates

6.4 Hologic, Inc.

6.4.1 Hologic, Inc. Company Information

6.4.2 Hologic, Inc. Description and Business Overview

6.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hologic, Inc. Molecular Diagnostics Systems Product Portfolio

6.4.5 Hologic, Inc. Recent Developments/Updates

6.5 Grifols

6.5.1 Grifols Company Information

6.5.2 Grifols Description and Business Overview

6.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Grifols Molecular Diagnostics Systems Product Portfolio

6.5.5 Grifols Recent Developments/Updates

6.6 Siemens Healthcare

6.6.1 Siemens Healthcare Company Information

6.6.2 Siemens Healthcare Description and Business Overview

6.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Siemens Healthcare Molecular Diagnostics Systems Product Portfolio

6.6.5 Siemens Healthcare Recent Developments/Updates

6.7 Becton, Dickinson and Company

6.7.1 Becton, Dickinson and Company Company Information

6.7.2 Becton, Dickinson and Company Description and Business Overview

6.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Product Portfolio

6.7.5 Becton, Dickinson and Company Recent Developments/Updates

6.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)

6.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Company Information

6.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview

6.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Portfolio

6.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates

6.9 Biomérieux Sa

6.9.1 Biomérieux Sa Company Information

6.9.2 Biomérieux Sa Description and Business Overview

6.9.3 Biomérieux Sa Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Biomérieux Sa Molecular Diagnostics Systems Product Portfolio

6.9.5 Biomérieux Sa Recent Developments/Updates

6.10 Cepheid Inc

6.10.1 Cepheid Inc Company Information

6.10.2 Cepheid Inc Description and Business Overview

6.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Cepheid Inc Molecular Diagnostics Systems Product Portfolio

6.10.5 Cepheid Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Molecular Diagnostics Systems Industry Chain Analysis

7.2 Molecular Diagnostics Systems Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Molecular Diagnostics Systems Production Mode & Process Analysis

7.4 Molecular Diagnostics Systems Sales and Marketing

7.4.1 Molecular Diagnostics Systems Sales Channels

7.4.2 Molecular Diagnostics Systems Distributors

7.5 Molecular Diagnostics Systems Customer Analysis

8 Molecular Diagnostics Systems Market Dynamics

8.1 Molecular Diagnostics Systems Industry Trends

8.2 Molecular Diagnostics Systems Market Drivers

8.3 Molecular Diagnostics Systems Market Challenges

8.4 Molecular Diagnostics Systems Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Becton Dickinson and Company

Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)

BioMérieux SA

Cepheid Inc

List of Tables

Table 1. Global Molecular Diagnostics Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Molecular Diagnostics Systems Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Molecular Diagnostics Systems Market Competitive Situation by Manufacturers in 2024

Table 4. Global Molecular Diagnostics Systems Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Molecular Diagnostics Systems Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Molecular Diagnostics Systems Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Molecular Diagnostics Systems Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Molecular Diagnostics Systems, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Molecular Diagnostics Systems, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Molecular Diagnostics Systems, Product Type & Application

Table 12. Global Key Manufacturers of Molecular Diagnostics Systems, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Molecular Diagnostics Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Molecular Diagnostics Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Molecular Diagnostics Systems Sales by Region (2020-2025) & (K Units)

Table 18. Global Molecular Diagnostics Systems Sales Market Share by Region (2020-2025)

Table 19. Global Molecular Diagnostics Systems Sales by Region (2026-2031) & (K Units)

Table 20. Global Molecular Diagnostics Systems Sales Market Share by Region (2026-2031)

Table 21. Global Molecular Diagnostics Systems Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Molecular Diagnostics Systems Revenue Market Share by Region (2020-2025)

Table 23. Global Molecular Diagnostics Systems Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Molecular Diagnostics Systems Revenue Market Share by Region (2026-2031)

Table 25. North America Molecular Diagnostics Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Molecular Diagnostics Systems Sales by Country (2020-2025) & (K Units)

Table 27. North America Molecular Diagnostics Systems Sales by Country (2026-2031) & (K Units)

Table 28. North America Molecular Diagnostics Systems Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Molecular Diagnostics Systems Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Molecular Diagnostics Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Molecular Diagnostics Systems Sales by Country (2020-2025) & (K Units)

Table 32. Europe Molecular Diagnostics Systems Sales by Country (2026-2031) & (K Units)

Table 33. Europe Molecular Diagnostics Systems Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Molecular Diagnostics Systems Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Molecular Diagnostics Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Molecular Diagnostics Systems Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Molecular Diagnostics Systems Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Molecular Diagnostics Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Molecular Diagnostics Systems Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Molecular Diagnostics Systems Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Molecular Diagnostics Systems Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Molecular Diagnostics Systems Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Molecular Diagnostics Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Molecular Diagnostics Systems Sales (K Units) by Type (2020-2025)

Table 51. Global Molecular Diagnostics Systems Sales (K Units) by Type (2026-2031)

Table 52. Global Molecular Diagnostics Systems Sales Market Share by Type (2020-2025)

Table 53. Global Molecular Diagnostics Systems Sales Market Share by Type (2026-2031)

Table 54. Global Molecular Diagnostics Systems Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Molecular Diagnostics Systems Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Molecular Diagnostics Systems Revenue Market Share by Type (2020-2025)

Table 57. Global Molecular Diagnostics Systems Revenue Market Share by Type (2026-2031)

Table 58. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2020-2025)

Table 59. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2026-2031)

Table 60. Global Molecular Diagnostics Systems Sales (K Units) by Application (2020-2025)

Table 61. Global Molecular Diagnostics Systems Sales (K Units) by Application (2026-2031)

Table 62. Global Molecular Diagnostics Systems Sales Market Share by Application (2020-2025)

Table 63. Global Molecular Diagnostics Systems Sales Market Share by Application (2026-2031)

Table 64. Global Molecular Diagnostics Systems Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Molecular Diagnostics Systems Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Molecular Diagnostics Systems Revenue Market Share by Application (2020-2025)

Table 67. Global Molecular Diagnostics Systems Revenue Market Share by Application (2026-2031)

Table 68. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2020-2025)

Table 69. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2026-2031)

Table 70. Abbott Laboratories Company Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Laboratories Molecular Diagnostics Systems Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Qiagen N.V. Company Information

Table 76. Qiagen N.V. Description and Business Overview

Table 77. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Qiagen N.V. Molecular Diagnostics Systems Product

Table 79. Qiagen N.V. Recent Developments/Updates

Table 80. Roche Diagnostics Company Information

Table 81. Roche Diagnostics Description and Business Overview

Table 82. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Roche Diagnostics Molecular Diagnostics Systems Product

Table 84. Roche Diagnostics Recent Developments/Updates

Table 85. Hologic, Inc. Company Information

Table 86. Hologic, Inc. Description and Business Overview

Table 87. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Hologic, Inc. Molecular Diagnostics Systems Product

Table 89. Hologic, Inc. Recent Developments/Updates

Table 90. Grifols Company Information

Table 91. Grifols Description and Business Overview

Table 92. Grifols Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Grifols Molecular Diagnostics Systems Product

Table 94. Grifols Recent Developments/Updates

Table 95. Siemens Healthcare Company Information

Table 96. Siemens Healthcare Description and Business Overview

Table 97. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Siemens Healthcare Molecular Diagnostics Systems Product

Table 99. Siemens Healthcare Recent Developments/Updates

Table 100. Becton, Dickinson and Company Company Information

Table 101. Becton, Dickinson and Company Description and Business Overview

Table 102. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Becton, Dickinson and Company Molecular Diagnostics Systems Product

Table 104. Becton, Dickinson and Company Recent Developments/Updates

Table 105. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Company Information

Table 106. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview

Table 107. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product

Table 109. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates

Table 110. Biomérieux Sa Company Information

Table 111. Biomérieux Sa Description and Business Overview

Table 112. Biomérieux Sa Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Biomérieux Sa Molecular Diagnostics Systems Product

Table 114. Biomérieux Sa Recent Developments/Updates

Table 115. Cepheid Inc Company Information

Table 116. Cepheid Inc Description and Business Overview

Table 117. Cepheid Inc Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Cepheid Inc Molecular Diagnostics Systems Product

Table 119. Cepheid Inc Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Molecular Diagnostics Systems Distributors List

Table 123. Molecular Diagnostics Systems Customers List

Table 124. Molecular Diagnostics Systems Market Trends

Table 125. Molecular Diagnostics Systems Market Drivers

Table 126. Molecular Diagnostics Systems Market Challenges

Table 127. Molecular Diagnostics Systems Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Molecular Diagnostics Systems

Figure 2. Global Molecular Diagnostics Systems Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Molecular Diagnostics Systems Market Share by Type: 2024 & 2031

Figure 4. PCR Product Picture

Figure 5. Hybridization Product Picture

Figure 6. DNA Sequencing Product Picture

Figure 7. Global Molecular Diagnostics Systems Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Molecular Diagnostics Systems Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Laboratories

Figure 11. Global Molecular Diagnostics Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Molecular Diagnostics Systems Market Size (2020-2031) & (US$ Million)

Figure 13. Global Molecular Diagnostics Systems Sales (2020-2031) & (K Units)

Figure 14. Global Molecular Diagnostics Systems Average Price (USD/Unit) & (2020-2031)

Figure 15. Molecular Diagnostics Systems Report Years Considered

Figure 16. Molecular Diagnostics Systems Sales Share by Manufacturers in 2024

Figure 17. Global Molecular Diagnostics Systems Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Molecular Diagnostics Systems Players: Market Share by Revenue in Molecular Diagnostics Systems in 2024

Figure 19. Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Molecular Diagnostics Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Molecular Diagnostics Systems Sales Market Share by Country (2020-2031)

Figure 22. North America Molecular Diagnostics Systems Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Molecular Diagnostics Systems Sales Market Share by Country (2020-2031)

Figure 26. Europe Molecular Diagnostics Systems Revenue Market Share by Country (2020-2031)

Figure 27. Germany Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Molecular Diagnostics Systems Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Molecular Diagnostics Systems Revenue Market Share by Region (2020-2031)

Figure 34. China Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Molecular Diagnostics Systems Sales Market Share by Country (2020-2031)

Figure 44. Latin America Molecular Diagnostics Systems Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Molecular Diagnostics Systems Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Molecular Diagnostics Systems Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Molecular Diagnostics Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Molecular Diagnostics Systems by Type (2020-2031)

Figure 54. Global Revenue Market Share of Molecular Diagnostics Systems by Type (2020-2031)

Figure 55. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Molecular Diagnostics Systems by Application (2020-2031)

Figure 57. Global Revenue Market Share of Molecular Diagnostics Systems by Application (2020-2031)

Figure 58. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2020-2031)

Figure 59. Molecular Diagnostics Systems Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Hydrocolloid Waterproof Adhesive Bandages Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z19779

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adjustable Rollator Walker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Q20015

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Multi-Functional Point Of Care Testin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19G20218

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions